This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm of other and unspecified female genital organs
CD2_BENIGN_FEMALE_GEN_OTH_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna organorum genitalium femininorum aliorum et non specificatorum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of other and unspecified female genital organs
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of other and unspecified female genital organs
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1601 | 1601 | - |
| Unadjusted period prevalence (%) | 0.55 | 0.55 | - |
| Median age at first event (years) | 41.01 | 41.01 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1436
- Matched controls
- 14360
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D28.0
ICD-10 Finland
Benign neoplasm: Vulva
3076.6
323.0
459
*
D28.1
ICD-10 Finland
Benign neoplasm: Vagina
1666.8
288.5
271
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
50.6
163.1
197
45
22120
ICD-8 Finland
Benign neoplasm of other female genital organs, Vulva
+∞
129.1
122
*
115
Kela drug reimbursment
Breast cancer
+∞
129.1
122
*
PJA12
NOMESCO Finland
Sentinel node biopsy
420.9
118.4
117
*
22101
ICD-8 Finland
Benign neoplasm of other female genital organs, Fallopian tube and broad ligament
+∞
107.7
102
*
22110
ICD-8 Finland
Benign neoplasm of other female genital organs, Vagina
+∞
97.0
92
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
91.7
87
*
D28.2
ICD-10 Finland
Benign neoplasm: Uterine tubes and ligaments
+∞
76.8
73
*
LEB10
NOMESCO Finland
Excision of lesion of vagina
31.8
73.6
98
33
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
68.3
65
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
59.8
57
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
303.9
57.7
58
*
2210A
ICD-9 Finland
Benign neoplasm of other female genital organs, Fallopian tube and uterine ligaments
+∞
57.7
55
*
H02AB02
ATC
dexamethasone; systemic
16.3
56.2
92
60
D28.9
ICD-10 Finland
Benign neoplasm: Female genital organ, unspecified
569.5
56.0
55
*
HAC20
NOMESCO Finland
Total mastectomy
148.3
54.2
57
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
102.5
54.2
59
6
L02BG04
ATC
letrozole; oral
13.8
51.9
91
70
22121
ICD-8 Finland
NA
+∞
51.4
49
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
50.3
48
*
22122
ICD-8 Finland
NA
+∞
50.3
48
*
L02BA01
ATC
tamoxifen; oral
91.7
48.2
53
6
HAB40
NOMESCO Finland
Wedge excision of mammary gland
19.7
47.9
73
39
A04AA02
ATC
granisetron; systemic, transdermal
68.7
46.4
53
8
130
Kela drug reimbursment
Malignant tumour
+∞
45.0
43
*
C50.99
ICD-10 Finland
Breast, unspecified
451.2
44.5
44
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
408.6
40.3
40
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
398.0
39.3
39
*
D28.7
ICD-10 Finland
Benign neoplasm: Other specified female genital organs
+∞
37.7
36
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
70.2
36.1
41
6
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
35.6
34
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
35.6
34
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
32.4
31
*
L02BG03
ATC
anastrozole; oral
168.8
31.8
33
*
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
18.1
31.6
49
28
A04AA55
ATC
palonosetron, combinations; systemic
+∞
30.3
29
*
C50
ICD-10 Finland
Malignant neoplasm of breast
308.6
29.9
30
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
29.5
263
1182
22199
ICD-8 Finland
Benign neoplasm of other female genital organs, Unspecified site
+∞
29.3
28
*
2211A
ICD-9 Finland
Benign neoplasm of other female genital organs, Vagina
+∞
28.2
27
*
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
4.8
27.6
95
209
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
25.1
24
*
X76
ICPC
Malignant neoplasm breast female
+∞
25.1
24
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
25.1
24
*
HA1AA
NOMESCO Finland
X-ray mammography
4.0
24.5
101
265
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.5
24.1
217
972
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
23.8
411
2457
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.4
23.6
88
210
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
23.0
22
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
23.0
22
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
66.1
22.9
26
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
233.6
22.7
23
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
21.9
21
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
223.3
21.7
22
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
31.7
21.5
28
9
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
78.0
20.7
23
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
19.8
19
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
19.8
19
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
18.8
18
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
18.8
18
*
ZX080
NOMESCO Finland
Image guided radiotherapy
192.4
18.6
19
*
JN4BD
NOMESCO Finland
Extensive body CT
3.6
18.6
85
245
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
44.6
18.3
22
5
XX3DW
NOMESCO Finland
Time consuming IT work
3.4
18.1
90
277
L02BG06
ATC
exemestane; oral
+∞
17.7
17
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
17.7
17
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
96.3
17.6
19
*
TQW20
NOMESCO Finland
Tatoe
50.6
17.0
20
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
16.7
16
*
22111
ICD-8 Finland
NA
+∞
16.7
16
*
A04AD12
ATC
aprepitant; systemic
+∞
16.7
16
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
40.6
16.3
20
5
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.1
15.7
196
1013
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
15.6
15
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
15.6
15
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
15.6
15
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
86.0
15.6
17
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
32.1
14.8
19
6
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
57.3
14.8
17
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.6
14
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
14.6
14
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
14.6
14
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
14.6
14
*
L01BC06
ATC
capecitabine; oral
+∞
14.6
14
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
14.3
495
3550
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
12.1
14.1
25
21
8412
FHL
Vaginal tumor removal
75.9
13.6
15
*
LEB20
NOMESCO Finland
Marsupialisation of vaginal cyst
75.9
13.6
15
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
13.6
13
*
JN4AD
NOMESCO Finland
Body CT examination
3.8
13.3
56
152
HAB99
NOMESCO Finland
Other partial excision of mammary gland
6.4
13.2
34
54
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
13.1
518
3822
LEB00
NOMESCO Finland
Biopsy of vagina
4.2
12.9
49
121
N02BE01
ATC
paracetamol; systemic, rectal
1.7
12.8
1228
11109
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.4
12.8
46
108
S18
ICPC
Laceration/cut
1.5
12.8
534
3982
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
7.9
12.6
28
36
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
12.5
12
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
12.5
12
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
6.8
12.2
30
45
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.9
12.1
201
1154
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
12.0
256
1594
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.5
11.7
938
8007
J01DB01
ATC
cefalexin; oral
1.6
11.6
1122
9976
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.1
11.6
64
215
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
11.5
514
3867
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
11.5
11
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
11.5
11
*
TQW99
NOMESCO Finland
Other minor procedure on skin
3.2
11.3
60
196
A02BC02
ATC
pantoprazole; systemic
1.5
11.3
897
7608
J02AC01
ATC
fluconazole; systemic
1.5
11.1
688
5538
LCD00
NOMESCO Finland
Hysterectomy
2.4
11.1
98
432
UKC02
NOMESCO Finland
Cystoscopy
1.9
10.8
156
851
N75.0
ICD-10 Finland
Cyst of Bartholin gland
5.1
10.8
33
66
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
10.8
138
719
L03AA02
ATC
filgrastim; parenteral
28.2
10.7
14
5
ZX090
NOMESCO Finland
Other technic of radiotherapy
60.5
10.6
12
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
60.5
10.6
12
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
10.4
10
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
10.4
10
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
10.4
10
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
10.4
10
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
10.4
10
*
N02AX02
ATC
tramadol; systemic, rectal
1.5
10.3
536
4144
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
10.3
313
2142
Z31.5
ICD-10 Finland
Genetic counselling
2.9
10.2
63
227
N90.7
ICD-10 Finland
Vulvar cyst
9.2
10.0
20
22
A04AA01
ATC
ondansetron; systemic, rectal
3.2
10.0
51
163
SPAT1153
SPAT
Removal of sutures
1.5
10.0
405
2962
N02AA05
ATC
oxycodone; systemic
2.0
10.0
134
710
WF002
NOMESCO Finland
Radical radiotherapy
20.2
9.8
14
7
A79
ICPC
Malignancy NOS
55.4
9.7
11
*
Z51.0
ICD-10 Finland
Radiotherapy session
100.7
9.4
10
*
2218X
ICD-9 Finland
Benign neoplasm of other female genital organs, Other specified sites of female genital organs
+∞
9.4
9
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
9.3
496
3832
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
10.7
9.3
17
16
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
36.9
9.0
11
*
JAH01
NOMESCO Finland
Laparoscopy
2.4
8.9
73
311
WZC30
NOMESCO Finland
Teaching
2.0
8.7
117
623
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
3.2
8.7
43
136
8473
FHL
Guinea pig or gland excision
9.0
8.5
17
19
JN4CD
NOMESCO Finland
Very extensive body CT
4.6
8.5
28
62
J01DA01
ATC
[U] cefalexin; systemic
1.4
8.5
870
7530
D82
ICPC
Teeth/gum disease
1.4
8.5
456
3514
61610
ICD-8 Finland
Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female
4.0
8.5
32
81
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
12.8
8.4
14
11
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
8.3
8
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
8.3
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
8.3
8
*
62212
ICD-8 Finland
Infective diseases of uterus (except cervix), vagina and vulva, Bartholinitis acuta
9.5
8.3
16
17
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
8.2
523
4156
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
4.0
8.2
31
79
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
33.5
8.1
10
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
33.5
8.1
10
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.1
8.1
30
75
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
8.1
373
2788
21899
ICD-8 Finland
Uterine fibroma
2.0
7.9
92
465
A06AD11
ATC
lactulose; oral
1.7
7.8
165
1021
TQB05
NOMESCO Finland
Puncture of skin of trunk
15.1
7.7
12
8
E0000UV
ATC
NA
1.4
7.7
521
4172
UJF32
NOMESCO Finland
Coloscopy
1.5
7.6
324
2381
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.5
7.6
282
2010
J01AA02
ATC
doxycycline; systemic
1.4
7.5
1106
10072
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.3
7.5
67
301
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
7.4
312
2282
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
80.5
7.4
8
*
LFC00
NOMESCO Finland
Partial excision of vulva
13.4
7.4
12
9
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.1
7.4
83
411
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
7.3
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
7.3
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
+∞
7.3
7
*
PJW99
NOMESCO Finland
Other operation on lymphatic system
+∞
7.3
7
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
7.3
7
*
ULA02
NOMESCO Finland
Kolposcopy
1.7
7.2
161
1014
X01
ICPC
Genital pain female
5.2
6.9
20
39
N36.1
ICD-10 Finland
Urethral diverticulum
13.8
6.9
11
8
8204
FHL
Salpingo-oophorectomy
3.1
6.9
36
120
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
2.5
6.9
49
197
M54.5
ICD-10 Finland
Low back pain
1.4
6.8
448
3551
ZX120
NOMESCO Finland
Intravenous
2.0
6.8
86
450
J01MA12
ATC
levofloxacin; systemic
1.6
6.8
196
1315
D70.82
ICD-10 Finland
Drug-induced neutropenia
9.4
6.8
13
14
WX110
NOMESCO Finland
Local anesthesy
1.3
6.7
887
7841
B01AB05
ATC
enoxaparin; parenteral
1.4
6.7
349
2657
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
6.6
121
716
M01AE02
ATC
naproxen; oral, rectal
1.3
6.6
780
6775
WX402
NOMESCO Finland
General anaesthesia
1.6
6.6
164
1061
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.0
6.5
75
379
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
5.1
6.5
19
38
N39.3
ICD-10 Finland
Stress incontinence
1.6
6.4
149
947
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
70.2
6.4
7
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
70.2
6.4
7
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
70.2
6.4
7
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
70.2
6.4
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
70.2
6.4
7
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
70.2
6.4
7
*
A02BC05
ATC
esomeprazole; systemic
1.3
6.4
557
4612
N89.9
ICD-10 Finland
Noninflammatory disorder of vagina, unspecified
7.4
6.4
14
19
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.4
583
4857
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
+∞
6.3
6
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
6.3
6
*
8520/3-C50.2
ICD-O-3
Lobular carcinoma, NOS, of upper-inner quadrant of breast
+∞
6.3
6
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
+∞
6.3
6
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
+∞
6.3
6
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
6.3
6
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
6.3
6
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
6.3
6
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
6.3
6
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
6.3
6
*
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
6.3
6
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.9
6.2
36
127
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
6.2
360
2785
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
6.2
693
5944
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
26.8
6.2
8
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
26.8
6.2
8
*
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
6.2
1237
11619
M25.5
ICD-10 Finland
Pain in joint
1.4
6.2
406
3210
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.2
456
3675
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
6.3
6.2
15
24
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
6.1
95
536
NK6AN
NOMESCO Finland
Total body bone isotope imaging
8.6
6.1
12
14
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
6.0
412
3277
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.6
6.0
169
1127
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
6.0
93
522
22099
ICD-8 Finland
Benign neoplasm of ovary, Other and unspecified
2.9
6.0
33
115
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
172
668
2.76
30.90
3.4
1.4
6.4
21.8
ug/l
0.39
132
490
825
6200
1.68
22.59
5.0
3.5
9.9
10.2
umol/l
0.36
775
5729
309
1802
1.89
20.30
5.0
4.7
34.2
33.7
%
0.36
231
1187
757
5758
1.60
18.32
3.8
3.6
—
—
—
0
0
411
2764
1.66
16.02
2.2
1.9
—
—
—
0
0
1183
10156
1.63
15.99
7.2
5.3
76.1
75.3
u/l
0.33
1103
9337
748
5815
1.54
15.54
5.4
4.7
1.2
1.2
mmol/l
0.20
644
5130
149
789
1.98
12.80
2.1
1.5
26.3
27.3
u/ml
0.05
144
753
534
4135
1.44
10.02
2.4
2.2
58.3
57.5
u/l
0.09
489
3763
787
6533
1.40
9.92
6.5
5.2
1.2
1.2
mmol/l
0.04
642
5499
155
910
1.78
9.65
1.9
2.1
0.2
0.2
g/l
0.75
142
838
55
224
2.51
9.02
1.3
1.3
—
—
—
0
0
607
4901
1.38
8.65
3.5
3.4
25.9
55.9
ng/l
1.11
367
3132
846
7215
1.37
8.51
8.2
6.5
4.1
4.0
e9/l
0.15
747
6184
1177
10610
1.41
8.30
4.5
4.3
12.0
12.2
mm/h
0.27
1078
9826
984
8626
1.37
8.14
3.3
2.8
43.3
38.2
u/l
0.96
910
7944
1043
9260
1.36
7.75
5.5
4.7
4779.1
2807.1
e6/l
0.20
15
118
107
604
1.83
7.61
3.5
3.3
1.9
2.0
mmol/l
0.08
83
456
110
633
1.79
7.35
3.6
3.4
5.2
5.2
kpa
0.03
104
584
45
185
2.47
7.29
1.4
1.3
28.6
28.6
u/l
0.00
35
140
1488
14169
1.71
7.06
15.6
13.2
139.8
139.8
mmol/l
0.05
1453
13761
1491
14211
1.72
6.97
15.7
13.3
3.9
3.9
mmol/l
0.17
1453
13774
78
412
1.94
6.82
3.9
3.6
25.4
24.9
mmol/l
0.68
70
374
857
7466
1.32
6.80
4.1
3.8
6.6
6.6
mmol/l
0.15
796
6832
541
4450
1.33
6.35
2.9
2.0
2.4
2.4
mmol/l
0.59
441
3744
83
462
1.84
6.21
2.1
2.0
10878.0
3948.4
u/l
0.49
37
201
1440
13691
1.51
5.84
14.2
11.5
19.0
19.6
mg/l
0.29
1164
10457
11
21
5.27
5.53
1.4
1.1
—
—
—
0
0
37
161
2.33
5.37
1.4
1.4
—
—
—
0
0
76
432
1.80
5.36
1.9
1.7
—
—
—
0
0
37
162
2.31
5.30
1.5
1.4
—
—
—
0
0
231
1707
1.41
5.27
2.9
2.3
0.8
0.8
mmol/l
0.29
205
1551
79
457
1.77
5.26
2.0
1.8
—
—
—
0
0
37
164
2.29
5.16
1.5
1.4
—
—
—
0
0
623
5340
1.27
5.07
4.4
3.7
35.7
36.0
g/l
0.78
572
4879
37
169
2.22
4.83
1.5
1.4
—
—
—
0
0
177
1266
1.45
4.83
2.0
1.8
379.5
365.2
nmol/l
0.44
152
1146
1368
12969
1.38
4.81
12.5
10.3
79.9
79.9
ml/min/173m2
0.05
1145
10325
21
73
2.90
4.77
3.8
1.1
392.0
100.7
u/ml
—
8
26
34
151
2.28
4.75
1.6
1.1
2.3
2.8
ug/l
0.52
26
135
62
348
1.81
4.60
2.1
1.8
4.0
1.6
ug/l
0.60
49
294
37
173
2.17
4.58
1.5
1.3
—
—
—
0
0
15
44
3.43
4.47
1.5
1.3
—
—
—
0
0
15
44
3.43
4.47
1.5
1.3
—
—
—
0
0
36
170
2.14
4.36
1.5
1.3
—
—
—
0
0
322
2587
1.31
4.25
1.8
1.7
1223.8
1188.9
nmol/l
0.23
236
1929
47
248
1.92
4.23
3.3
1.9
160.5
102.4
u/ml
0.20
40
198
203
1530
1.37
4.12
17.9
23.5
1.3
1.3
inr
0.06
27
224
428
3587
1.26
4.03
2.6
2.9
926.9
1167.1
ng/l
0.74
352
3020
7
7
10.04
4.01
1.1
1.3
—
—
—
0
0
37
184
2.03
3.95
1.8
1.3
0.4
0.4
nmol/l
0.25
29
152
62
366
1.72
3.92
1.4
1.3
—
—
—
0
0
22
88
2.52
3.89
1.8
1.3
—
—
—
0
0
1066
11382
0.81
3.75
17.0
13.9
13.7
13.6
%
0.98
1042
11087
52
298
1.77
3.66
1.4
1.3
—
—
—
0
0
381
3190
1.26
3.57
2.3
2.1
5177.2
5519.2
umol/l
0.05
322
2707
714
6391
1.21
3.52
2.4
2.3
81.1
80.1
nmol/l
0.43
612
5703
117
825
1.45
3.49
1.8
1.6
—
—
—
0
0
1505
14640
1.47
3.31
11.0
9.0
23.6
23.0
u/l
0.67
1449
14020
14
49
2.87
3.19
2.9
1.8
947.2
797.0
e6/l
—
9
22
19
79
2.42
3.14
1.7
1.2
—
—
—
0
0
19
79
2.42
3.14
1.7
1.2
—
—
—
0
0
19
79
2.42
3.14
1.7
1.2
—
—
—
0
0
220
1749
1.30
3.12
6.8
6.1
—
—
—
0
0
655
5875
1.19
3.02
2.0
2.0
102.6
98.9
pmol/l
0.89
310
2744
20
87
2.32
3.01
1.1
1.1
14.3
14.7
iu/ml
—
5
19
8
17
4.72
2.92
1.9
2.4
1.1
1.0
u/field
—
8
17
10
30
3.35
2.91
1.4
1.2
—
—
—
0
0
9
22
4.11
2.88
3.6
2.0
—
—
—
0
0
22
102
2.17
2.87
1.8
1.3
—
—
—
0
0
24
116
2.09
2.83
1.4
1.2
—
—
—
0
0
473
4138
1.20
2.83
2.7
2.5
28.0
29.3
u/l
0.56
444
3918
337
2854
1.23
2.80
1.3
1.3
20.7
35.5
iu/ml
3.79
96
906
57
364
1.59
2.75
1.1
1.1
—
—
—
0
0
12
42
2.87
2.75
1.3
1.2
—
—
—
0
0
12
42
2.87
2.75
1.3
1.2
—
—
—
0
0
12
42
2.87
2.75
1.3
1.2
—
—
—
0
0
12
42
2.87
2.75
1.3
1.2
—
—
—
0
0
15
61
2.47
2.62
1.5
1.2
—
—
—
0
0
15
61
2.47
2.62
1.5
1.2
—
—
—
0
0
418
3644
1.20
2.57
4.4
4.4
0.0
0.0
estimate
0.34
149
1231
222
1812
1.26
2.57
2.0
1.7
—
—
—
0
0
386
3341
1.20
2.56
1.5
1.4
—
—
—
0
0
9
26
3.48
2.48
2.9
1.3
100.5
77.6
ng/l
—
9
26
12
45
2.68
2.45
1.6
1.7
6.0
4.0
mg/l
0.50
12
45
133
1023
1.33
2.43
3.5
3.3
235.6
232.3
u/l
0.16
120
957
22
110
2.01
2.41
2.0
1.7
279.7
1282.1
u/ml
0.37
22
103
353
3048
1.20
2.40
1.6
1.8
0.9
1.0
mg/l
0.47
264
2286
149
1169
1.30
2.37
2.9
2.2
1.9
1.8
%
0.29
120
1021
25
133
1.89
2.32
1.8
1.7
91.9
90.5
%
0.79
25
133
167
1335
1.28
2.31
2.0
2.1
5.8
5.4
umol/l
0.12
148
1115
9
28
3.23
2.31
1.0
1.0
—
—
—
0
0
43
269
1.62
2.30
2.4
2.9
—
—
—
0
0
91
666
1.39
2.29
1.5
1.5
—
—
—
0
0
34
200
1.72
2.29
2.6
2.2
16.6
16.3
%
0.22
15
96
7
18
3.90
2.25
1.3
1.1
—
—
—
0
0
9
30
3.01
2.15
1.4
1.2
—
—
—
0
0
9
30
3.01
2.15
1.4
1.2
—
—
—
0
0
160
1285
1.27
2.14
5.0
5.4
104.6
104.0
mmol/l
0.67
155
1256
470
4202
1.17
2.10
2.1
2.1
134.1
171.3
u/l
0.94
435
3924
28
161
1.75
2.06
2.1
2.0
28.1
24.9
mg/l
—
8
37
0
58
0.00
2.04
0.0
1.1
—
—
—
0
0
50
335
1.51
2.03
1.3
1.2
—
—
—
0
0
11
44
2.51
2.01
1.1
1.1
—
—
—
0
0
175
1435
1.25
1.98
5.1
4.7
1.1
1.0
mmol/l
0.48
158
1302
27
156
1.74
1.97
1.3
1.3
—
—
—
0
0
1230
11827
1.17
1.96
5.0
4.5
14.7
14.8
pmol/l
0.12
1107
10823
216
1817
1.22
1.93
2.2
2.1
107.8
117.9
ug/g
0.27
167
1400
753
7002
1.14
1.92
4.1
3.9
0.0
0.0
estimate
1.08
150
1213
152
1233
1.26
1.90
3.0
2.9
—
—
—
0
0
143
1153
1.26
1.88
5.7
6.2
2.1
1.4
mmol/l
1.33
113
885
224
1901
1.21
1.83
2.5
2.4
12.7
13.4
umol/l
0.85
204
1741
671
6213
1.14
1.79
3.0
2.8
87.2
85.2
ug/l
0.17
604
5742
184
1539
1.22
1.75
2.3
2.5
21.5
22.7
%
0.59
148
1295
142
1156
1.25
1.74
3.2
3.4
95.6
81.9
ng/l
0.78
118
981
20
110
1.83
1.73
1.2
1.1
—
—
—
0
0
62
450
1.39
1.71
1.7
1.7
1.6
1.6
g/l
0.13
52
391
1328
12890
1.18
1.70
6.0
5.7
39.5
39.3
mmol/mol
0.24
1216
11942
20
111
1.81
1.69
1.4
1.2
—
—
—
0
0
737
6884
1.13
1.68
4.0
3.9
0.0
0.0
estimate
0.00
147
1203
1383
13475
1.19
1.66
6.0
5.4
3.5
2.0
mu/l
0.42
1276
12404
312
2752
1.17
1.64
1.3
1.3
6.9
12.4
u/ml
0.98
120
1078
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
42
287
1.48
1.60
1.9
2.4
3.6
3.5
g/l
0.15
37
272
741
6940
1.13
1.59
5.4
5.2
0.0
0.0
estimate
0.50
144
1213
14
70
2.01
1.59
1.1
1.2
—
—
—
0
0
23
136
1.70
1.59
1.4
1.3
—
—
—
0
0
37
247
1.51
1.58
2.1
2.0
129.5
128.6
g/l
0.09
25
174
1546
15261
1.38
1.57
21.5
17.3
4.4
4.4
e12/l
1.81
1505
14766
1545
15251
1.37
1.55
21.5
17.3
263.7
263.8
e9/l
0.01
1507
14814
142
1173
1.23
1.54
5.7
6.2
5.2
5.1
kpa
0.66
135
1117
142
1173
1.23
1.54
5.8
6.2
12.5
12.0
kpa
0.57
134
1115
33
217
1.53
1.52
1.2
1.3
—
—
—
0
0
154
1287
1.22
1.50
2.0
1.9
—
—
—
0
0
1546
15267
1.37
1.50
21.6
17.4
131.8
132.7
g/l
2.67
1526
15020
13
65
2.01
1.48
1.9
1.9
—
—
—
0
0
137
1134
1.23
1.47
1.9
1.9
—
—
—
0
0
1545
15262
1.35
1.43
21.6
17.3
6.7
6.6
e9/l
0.64
1502
14763
74
571
1.31
1.42
1.8
2.0
40.2
39.6
u/l
0.08
59
503
102
821
1.26
1.41
7.2
7.1
8.8
9.5
mmol/l
0.56
93
782
32
213
1.51
1.41
1.7
1.3
—
—
—
0
0
7
29
2.42
1.39
1.4
1.1
—
—
—
0
0
20
119
1.69
1.38
1.4
1.4
—
—
—
0
0
197
1701
1.18
1.37
2.4
2.4
2.4
2.4
g/l
0.15
178
1570
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
273
1.44
1.36
1.9
4.0
0.3
0.4
u/ml
0.36
20
172
24
151
1.60
1.35
1.8
1.3
—
—
—
0
0
452
4146
1.13
1.34
3.3
3.0
6.6
6.4
mmol/l
0.31
374
3474
83
659
1.27
1.30
1.7
1.7
—
—
—
0
0
79
627
1.27
1.25
1.4
1.6
—
—
—
0
0
87
699
1.26
1.25
1.5
1.4
—
—
—
0
0
292
2619
1.14
1.24
2.5
2.4
5.9
7.8
e6/l
1.91
252
2253
56
425
1.33
1.23
1.5
1.7
—
303.0
—
0
27
17
100
1.71
1.23
1.0
1.0
—
—
—
0
0
33
467
0.70
1.23
1.8
1.3
10.3
10.3
g/l
0.00
24
386
30
207
1.46
1.15
1.7
1.3
—
—
—
0
0
29
199
1.47
1.15
2.8
2.5
8.7
8.1
kpa
1.08
29
184
898
8598
1.10
1.14
3.0
3.0
—
—
—
0
0
94
1138
0.82
1.14
1.7
1.6
—
—
—
0
0
30
208
1.45
1.13
1.1
1.1
—
—
—
0
0
1355
13265
1.14
1.12
4.3
4.0
1.2
1.3
mmol/l
0.21
1227
12092
11
58
1.90
1.12
1.0
1.4
—
—
—
0
0
98
811
1.22
1.11
1.6
1.7
—
—
—
0
0
28
193
1.46
1.09
1.7
1.3
277.1
323.4
pmol/l
0.37
23
146
334
3048
1.12
1.08
1.6
1.6
30741185.5
28651240.6
pmol/l
0.02
270
2520
16
97
1.66
1.06
1.0
1.1
—
—
—
0
0
5
22
2.28
1.03
1.0
1.2
1.4
1.5
umol/24h
—
5
22
53
413
1.29
1.01
1.4
1.5
—
—
—
0
0
42
318
1.33
0.98
1.7
1.6
8025.6
9818.0
e6/l
0.16
28
229
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
7
36
1.95
0.97
1.0
1.0
—
—
—
0
0
146
1271
1.16
0.97
1.8
1.6
1.4
1.4
%
1.38
125
1121
561
5287
1.09
0.97
4.3
4.1
—
—
—
0
0
446
4159
1.10
0.96
3.9
3.8
11.0
7.8
mg/mmol
0.54
244
2372
34
251
1.36
0.94
1.2
1.1
4.0
1.4
u/ml
0.55
14
104
363
3356
1.11
0.93
2.4
2.3
3.0
2.9
mg/l
0.22
306
2858
110
939
1.18
0.93
1.3
1.2
460.7
163.1
u/ml
0.41
102
856
191
1702
1.14
0.92
1.7
2.0
28.7
29.3
s
0.88
183
1644
1390
13665
1.13
0.92
5.0
4.6
5.8
5.8
mmol/l
0.14
1266
12458
1409
13864
1.14
0.92
4.8
4.5
4.8
4.9
mmol/l
3.16
1294
12837
6
28
2.15
0.91
1.0
1.2
—
—
—
0
0
29
394
0.73
0.90
1.9
1.3
38.2
38.1
g/l
0.01
22
328
368
3411
1.10
0.90
1.3
1.3
0.5
1.8
u/ml
5.94
96
910
30
219
1.38
0.89
1.2
1.2
—
—
—
0
0
10
56
1.79
0.88
2.0
2.3
—
—
—
0
0
10
56
1.79
0.88
1.1
1.3
—
—
—
0
0
16
103
1.56
0.87
2.2
2.5
—
—
—
0
0
1399
13768
1.13
0.87
4.8
4.5
1.6
1.6
mmol/l
0.44
1277
12674
36
273
1.33
0.86
1.8
1.7
—
—
—
0
0
6
114
0.52
0.83
1.7
1.5
1.1
1.0
g/l
—
6
114
39
499
0.78
0.82
2.1
1.3
3.7
3.8
g/l
0.16
24
346
10
58
1.73
0.79
2.2
2.4
632.7
883.5
u/ml
—
10
58
6
33
1.82
0.79
1.3
1.2
572.2
273.1
pmol/l
—
6
23
343
3195
1.09
0.76
1.5
1.5
23.0
22.0
nmol/l
0.56
264
2694
5
24
2.09
0.74
1.2
1.0
—
—
—
0
0
7
38
1.85
0.73
1.6
1.3
27.6
14.9
ug/l
—
7
38
115
1011
1.15
0.71
4.3
3.3
5.9
5.8
kpa
0.15
110
988
49
400
1.23
0.70
1.3
1.4
329.0
305.7
ug/g
0.31
28
221
9
143
0.63
0.69
1.2
1.3
—
—
—
0
0
39
310
1.26
0.69
1.6
1.5
—
—
—
0
0
31
239
1.30
0.69
1.5
1.2
0.6
0.6
nmol/l
0.02
31
230
77
659
1.18
0.68
1.2
1.3
0.2
1.2
u/ml
—
5
61
58
484
1.21
0.67
1.4
2.0
—
—
—
0
0
73
623
1.18
0.67
1.4
1.5
—
—
—
0
0
37
294
1.26
0.67
1.4
1.7
—
—
—
0
0
20
271
0.73
0.66
2.9
2.4
3.7
76.9
ug/min
—
7
168
33
415
0.79
0.64
1.8
1.4
0.6
0.3
g/l
0.23
28
355
12
79
1.52
0.62
1.9
1.7
—
—
—
0
0
1427
14105
1.11
0.62
5.2
5.0
2.8
2.9
mmol/l
2.51
1306
12990
110
976
1.14
0.62
2.8
1.4
66.2
67.4
g/l
0.87
98
865
10
63
1.59
0.61
1.0
1.1
—
—
—
0
0
10
63
1.59
0.61
1.0
1.1
—
—
—
0
0
116
1034
1.13
0.61
2.4
2.3
4.8
5.9
ug/l
0.56
91
896
41
499
0.82
0.60
2.0
1.3
7.8
7.5
g/l
0.37
27
363
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
41
498
0.82
0.60
2.0
1.3
—
—
—
0
0
8
52
1.54
0.59
1.0
1.2
0.3
0.3
g/l
—
8
39
46
550
0.83
0.58
1.6
1.7
3.5
3.8
mg/l
0.08
41
374
112
1001
1.13
0.57
4.4
3.3
2.3
2.1
mmol/l
0.25
94
838
26
202
1.29
0.57
1.3
1.8
—
—
—
0
0
116
1040
1.12
0.57
2.9
2.6
1.2
1.2
mmol/l
0.39
102
853
358
3386
1.07
0.57
3.0
2.9
0.3
0.4
e6/l
1.41
267
2504
16
115
1.40
0.56
1.6
2.3
2.1
2.8
u/field
—
10
47
266
2488
1.08
0.56
2.8
2.2
2.5
2.5
mmol/l
0.37
232
2150
17
124
1.37
0.55
1.2
2.3
—
1350.0
—
0
5
13
91
1.43
0.53
1.5
1.0
—
—
—
0
0
14
100
1.40
0.52
1.2
1.0
—
—
—
0
0
32
260
1.24
0.51
3.1
3.2
0.9
0.8
nmol/l
0.23
26
198
16
118
1.36
0.50
1.2
1.2
—
—
—
0
0
11
155
0.71
0.48
1.0
1.1
—
—
—
0
0
16
119
1.35
0.48
1.2
1.2
—
—
—
0
0
16
119
1.35
0.48
1.2
1.2
—
—
—
0
0
16
119
1.35
0.48
1.2
1.2
—
—
—
0
0
16
119
1.35
0.48
1.2
1.2
—
—
—
0
0
7
47
1.49
0.47
1.0
1.0
—
—
—
0
0
270
2551
1.07
0.45
1.6
1.5
—
—
—
0
0
28
228
1.23
0.45
1.5
1.5
—
—
—
0
0
20
156
1.29
0.45
1.6
1.4
—
—
—
0
0
7
50
1.40
0.45
1.0
1.2
113.7
114.8
%
—
7
42
42
357
1.18
0.45
2.0
2.2
15.8
11.3
mg/l
0.40
36
326
24
192
1.25
0.45
1.4
1.4
7.5
7.4
mmol/l
0.03
17
139
7
51
1.37
0.44
1.1
1.7
—
—
—
0
0
89
803
1.11
0.43
1.0
1.1
—
—
—
0
0
34
286
1.19
0.41
2.9
3.9
31.5
23.5
mg/l
0.30
17
175
40
466
0.85
0.41
2.0
1.3
3.0
3.0
g/l
0.03
24
357
321
3062
1.06
0.41
4.7
4.4
1.0
1.0
kg/l
0.04
50
469
19
238
0.80
0.40
1.2
2.2
1.0
0.8
nmol/l
0.60
13
188
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
49
428
1.15
0.39
1.7
1.6
0.6
0.1
iu/ml
—
9
76
14
106
1.32
0.39
2.7
3.6
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
1229
12439
0.95
0.39
14.5
12.9
38.9
39.0
%
0.13
845
8805
123
1138
1.09
0.37
2.0
2.1
30.9
34.2
u/l
0.57
105
949
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
15
116
1.30
0.37
1.5
1.3
4443.5
193249.4
e6/l
—
8
74
10
72
1.39
0.37
2.3
1.3
—
—
—
0
0
9
70
1.29
0.36
1.4
1.4
—
—
—
0
0
35
406
0.86
0.36
1.4
1.3
162.0
219.1
miu/ml
0.63
21
206
53
470
1.13
0.35
5.5
5.3
1.6
1.5
%
0.24
53
437
27
320
0.84
0.35
1.1
1.2
3.7
3.8
mmol/l
0.45
27
294
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
43
1.40
0.35
1.2
1.1
109.2
121.6
%
—
6
36
6
44
1.36
0.34
1.5
1.2
—
—
—
0
0
6
44
1.36
0.34
1.5
1.2
—
—
—
0
0
11
82
1.34
0.34
1.0
1.1
1.0
1.1
u/l
—
6
42
57
511
1.12
0.33
5.8
7.3
25.4
24.5
mmol/l
0.95
49
470
12
92
1.31
0.32
1.7
1.3
—
—
—
0
0
7
52
1.35
0.31
1.4
1.2
—
—
—
0
0
12
93
1.29
0.30
1.3
1.3
—
—
—
0
0
92
853
1.08
0.29
3.2
2.8
4.4
4.6
kpa
0.62
87
833
24
281
0.85
0.29
2.4
2.6
1.4
1.5
mmol/l
0.46
24
272
8
110
0.73
0.29
1.1
1.2
2.1
2.2
mmol/l
—
8
105
12
94
1.28
0.28
1.3
1.3
—
—
—
0
0
38
337
1.13
0.27
1.3
1.2
—
—
—
0
0
14
172
0.81
0.27
1.1
1.4
99.0
110.7
u/ml
—
6
32
17
204
0.83
0.27
1.6
1.2
1.2
2.8
u/ml
—
5
64
8
66
1.21
0.26
1.1
1.1
—
—
—
0
0
32
363
0.88
0.26
1.7
1.5
—
—
—
0
0
15
123
1.22
0.25
2.1
1.3
—
—
—
0
0
40
445
0.90
0.25
2.5
1.9
6.7
5.1
iu/l
0.31
13
155
46
416
1.11
0.25
1.0
1.1
1.4
5.7
u/ml
—
5
51
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
77
1.17
0.24
1.0
1.1
—
—
—
0
0
15
124
1.21
0.24
1.1
1.2
—
56.1
—
0
18
6
85
0.70
0.24
1.2
1.2
—
—
—
0
0
23
199
1.16
0.23
1.1
1.1
—
—
—
0
0
68
631
1.08
0.23
1.5
1.5
—
—
—
0
0
5
40
1.25
0.22
1.0
1.0
—
—
—
0
0
5
40
1.25
0.22
1.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
22.7
—
0
6
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
40
364
1.10
0.20
1.4
1.3
—
—
—
0
0
6
52
1.15
0.19
1.2
1.2
—
—
—
0
0
22
194
1.14
0.18
1.1
1.2
—
—
—
0
0
7
61
1.15
0.17
1.1
1.3
—
—
—
0
0
25
224
1.12
0.17
1.3
1.5
—
—
—
0
0
27
244
1.11
0.16
2.7
3.8
59.6
57.2
%
0.60
27
244
8
70
1.14
0.16
2.0
1.9
25.4
9.6
nmol/l
—
8
53
47
438
1.08
0.16
1.2
1.2
—
—
—
0
0
71
672
1.06
0.15
1.4
1.3
28.5
29.8
iu/l
0.12
65
584
6
76
0.79
0.15
1.0
1.1
—
—
—
0
0
24
265
0.90
0.15
2.4
2.7
7.8
7.6
mmol/l
0.07
24
256
57
537
1.06
0.14
2.9
2.4
1.2
1.1
%
0.52
57
532
31
336
0.92
0.14
1.5
1.4
—
—
—
0
0
99
1030
0.96
0.13
2.4
2.3
59.6
68.0
ml/min/173m2
1.68
37
414
31
335
0.92
0.13
1.5
1.4
—
—
—
0
0
31
334
0.93
0.12
1.5
1.4
—
—
—
0
0
31
334
0.93
0.12
1.5
1.4
—
—
—
0
0
97
1006
0.96
0.12
5.8
2.9
4.6
4.5
pmol/l
0.39
84
877
49
464
1.06
0.11
1.6
1.8
—
—
—
0
0
15
134
1.12
0.11
1.0
1.1
—
—
—
0
0
130
1264
1.03
0.10
1.9
1.7
—
—
—
0
0
20
183
1.09
0.10
1.8
1.5
45.5
59.9
%
—
10
114
24
222
1.08
0.10
1.4
1.5
—
—
—
0
0
12
106
1.13
0.09
1.3
1.1
—
—
—
0
0
242
2461
0.98
0.09
3.6
3.6
381.4
316.3
ng/l
0.14
172
1801
52
498
1.05
0.09
4.6
3.7
24.6
24.3
mmol/l
0.22
46
447
55
528
1.04
0.08
3.4
3.4
49.6
48.1
%
0.15
55
521
5
60
0.83
0.08
1.2
1.1
—
54.6
%
—
0
5
5
62
0.81
0.08
1.0
1.1
1762.0
1781.8
miu/ml
—
5
62
120
1172
1.03
0.08
1.2
1.2
179.3
153.5
iu/ml
0.32
44
460
7
66
1.06
0.08
2.0
1.3
—
—
—
0
0
7
67
1.04
0.08
1.4
1.4
5.4
4.7
umol/l
—
7
61
78
757
1.03
0.07
1.5
1.4
—
—
—
0
0
46
441
1.04
0.07
1.2
1.2
—
—
—
0
0
15
137
1.10
0.07
1.2
1.1
50.9
60.4
u/l
—
10
92
392
3960
0.99
0.07
1.7
1.6
1.3
1.3
mmol/l
0.27
339
3348
108
1058
1.02
0.06
2.8
3.0
275.3
173.4
ng/l
0.59
102
950
29
303
0.96
0.05
2.1
1.6
—
—
—
0
0
207
2047
1.01
0.05
2.7
2.5
1.3
1.6
e6/l
0.42
128
1137
34
352
0.97
0.04
1.1
1.2
459.2
465.8
mg/l
0.04
34
327
19
180
1.06
0.04
1.1
1.2
317.2
259.5
u/ml
—
10
110
21
200
1.05
0.03
1.0
1.0
3.6
2.2
u/ml
—
8
83
46
448
1.03
0.03
1.8
1.8
—
—
—
0
0
15
159
0.94
0.03
1.0
1.1
—
—
—
0
0
21
219
0.96
0.03
1.7
1.3
—
—
—
0
0
21
219
0.96
0.03
1.7
1.3
—
—
—
0
0
13
122
1.07
0.02
1.1
1.5
—
—
—
0
0
17
163
1.04
0.01
1.1
1.1
—
—
—
0
0
21
203
1.03
0.01
1.4
1.2
3.3
4.8
u/ml
0.47
11
79
12
116
1.03
0.00
1.8
1.2
1.5
1.8
u/ml
—
5
42
33
334
0.99
0.00
3.8
1.4
2.4
1.5
ratio
—
5
37
184
1836
1.00
0.00
2.7
2.6
5.4
4.5
e6/l
0.35
104
928
14
139
1.01
0.00
1.1
1.2
107.0
93.4
%
0.83
14
131
22
217
1.01
0.00
1.5
1.6
—
—
—
0
0
127
1267
1.00
0.00
1.9
1.6
—
—
—
0
0
33
325
1.02
0.00
1.2
1.2
—
18.6
—
0
6
11
115
0.96
0.00
2.1
1.8
32.9
32.2
pg
0.32
11
115
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
8
79
1.01
0.00
1.3
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
73.7
—
0
6
6
63
0.95
0.00
1.2
1.9
—
—
—
0
0
5
50
1.00
0.00
1.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
67
0.90
0.00
15.2
12.3
0.7
0.7
mmol/l
—
6
62
9
92
0.98
0.00
1.8
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
9
93
0.97
0.00
1.9
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
254.7
—
0
7
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
7
70
1.00
0.00
5.0
1.8
—
—
—
0
0
6
60
1.00
0.00
1.3
1.5
14.7
14.8
pmol/l
—
6
49
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
2.6
—
5.1
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_FEMALE_GEN_OTH_EXALLC – Benign neoplasm of other and unspecified female genital organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).